Death after Velagliflozin (Senvelgo) in cats

380 reports to the FDA describe death in cats given Velagliflozin. That is 7.9% of all reports for this medicine, compared with 8.9% across reports for all cat medicines.

380Reports
100%Marked serious
0.0%Recovered
100%Died or euthanised
4 daysTypical onset
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

How soon it started

Same day
35 10%
1–2 days
91 26%
3–7 days
91 26%
1–4 weeks
61 18%
Over a month
68 20%

How the animals did

Died
80 21%
Euthanised
299 79%
Not known
1 0.3%

Problems reported at the same time

Age of the animals

Under 1 year
0
1–3 years
10
4–7 years
49
8–11 years
155
12+ years
151

About this medicine

Velagliflozin treats diabetes in cats (oral, an SGLT2 inhibitor).

Products with this ingredient include Senvelgo. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Velagliflozin cause death in cats?
380 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?
In half of the reports with dates, it started within 4 days of the first dose.
What should I do?
Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Death with similar medicines

All reported side effects of Velagliflozin in cats · Medicines most reported with death